nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferiprone—UGT1A6—prostate gland—prostate cancer	0.0233	0.694	CbGeAlD
Deferiprone—UGT1A6—Glucuronidation—UGT2B17—prostate cancer	0.0121	0.0298	CbGpPWpGaD
Deferiprone—UGT1A6—Oxidative Stress—TXNRD2—prostate cancer	0.0117	0.0286	CbGpPWpGaD
Deferiprone—UGT1A6—Estrogen metabolism—SULT1E1—prostate cancer	0.011	0.027	CbGpPWpGaD
Deferiprone—UGT1A6—testis—prostate cancer	0.0103	0.306	CbGeAlD
Deferiprone—UGT1A6—Estrogen metabolism—SULT1A1—prostate cancer	0.00824	0.0202	CbGpPWpGaD
Deferiprone—UGT1A6—Estrogen metabolism—GSTA1—prostate cancer	0.00805	0.0197	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—CYP3A5—prostate cancer	0.00612	0.015	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—GSTCD—prostate cancer	0.00541	0.0133	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—GSTK1—prostate cancer	0.00541	0.0133	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—GSTA2—prostate cancer	0.00527	0.0129	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—SULT1A1—prostate cancer	0.0052	0.0128	CbGpPWpGaD
Deferiprone—UGT1A6—Estrogen metabolism—NQO1—prostate cancer	0.00513	0.0126	CbGpPWpGaD
Deferiprone—UGT1A6—Estrogen metabolism—CYP3A4—prostate cancer	0.005	0.0123	CbGpPWpGaD
Deferiprone—UGT1A6—Estrogen metabolism—CYP1B1—prostate cancer	0.00492	0.0121	CbGpPWpGaD
Deferiprone—UGT1A6—Oxidative Stress—NFE2L2—prostate cancer	0.00472	0.0116	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—UGT2B17—prostate cancer	0.00458	0.0112	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—UGT2B15—prostate cancer	0.00458	0.0112	CbGpPWpGaD
Deferiprone—UGT1A6—Oxidative Stress—GPX3—prostate cancer	0.0045	0.011	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—SULT2A1—prostate cancer	0.00448	0.011	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—SULT2B1—prostate cancer	0.00431	0.0106	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GSTM3—prostate cancer	0.00431	0.0106	CbGpPWpGaD
Deferiprone—UGT1A6—Estrogen metabolism—COMT—prostate cancer	0.0043	0.0105	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—NAT1—prostate cancer	0.00408	0.01	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—CYP2C19—prostate cancer	0.00399	0.00979	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—GSTA2—prostate cancer	0.00394	0.00966	CbGpPWpGaD
Deferiprone—UGT1A6—Estrogen metabolism—GSTM1—prostate cancer	0.00393	0.00964	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—CYP2A6—prostate cancer	0.00385	0.00944	CbGpPWpGaD
Deferiprone—UGT1A6—Estrogen metabolism—CYP1A1—prostate cancer	0.00373	0.00914	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—NCOA2—prostate cancer	0.00351	0.00862	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—AHR—prostate cancer	0.00344	0.00843	CbGpPWpGaD
Deferiprone—UGT1A6—Oxidative Stress—NQO1—prostate cancer	0.00341	0.00836	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—NFE2L2—prostate cancer	0.00335	0.00821	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—CBR1—prostate cancer	0.00329	0.00806	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—CYP3A4—prostate cancer	0.00316	0.00774	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—SULT1E1—prostate cancer	0.00309	0.00759	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—NCOA1—prostate cancer	0.00296	0.00726	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—GSTM3—prostate cancer	0.00287	0.00704	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—RXRA—prostate cancer	0.00282	0.00691	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—UGT2B15—prostate cancer	0.00268	0.00657	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—UGT2B17—prostate cancer	0.00268	0.00657	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—UGT2B17—prostate cancer	0.00264	0.00648	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GSTA3—prostate cancer	0.00263	0.00645	CbGpPWpGaD
Deferiprone—UGT1A6—Oxidative Stress—SOD2—prostate cancer	0.00262	0.00643	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—SLC39A1—prostate cancer	0.0026	0.00637	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GSTM3—prostate cancer	0.00252	0.00618	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—SULT2B1—prostate cancer	0.00252	0.00618	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—SULT2B1—prostate cancer	0.00248	0.00609	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—GSTM3—prostate cancer	0.00248	0.00609	CbGpPWpGaD
Deferiprone—UGT1A6—Oxidative Stress—CYP1A1—prostate cancer	0.00248	0.00607	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—NQO1—prostate cancer	0.00242	0.00594	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GSTA4—prostate cancer	0.00241	0.0059	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP3A43—prostate cancer	0.00239	0.00586	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—NAT1—prostate cancer	0.00239	0.00586	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP3A43—prostate cancer	0.00236	0.00577	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GSTA2—prostate cancer	0.00234	0.00575	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—CYP1B1—prostate cancer	0.00232	0.00569	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—SULT1A1—prostate cancer	0.00232	0.00568	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GSTA1—prostate cancer	0.00226	0.00555	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—NAT2—prostate cancer	0.00224	0.00548	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GSTO1—prostate cancer	0.00224	0.00548	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—NCOA1—prostate cancer	0.00221	0.00543	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—EPHX1—prostate cancer	0.002	0.00491	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—SULT2A1—prostate cancer	0.00199	0.00489	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP7B1—prostate cancer	0.00186	0.00455	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP7B1—prostate cancer	0.00183	0.00449	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—SULT1E1—prostate cancer	0.00181	0.00444	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—BAX—prostate cancer	0.00181	0.00444	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—HPGDS—prostate cancer	0.00179	0.00438	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—SULT1E1—prostate cancer	0.00178	0.00438	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—CYP1A1—prostate cancer	0.00176	0.00431	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—GSTA3—prostate cancer	0.00175	0.0043	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GSTT1—prostate cancer	0.00173	0.00425	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—GSTA4—prostate cancer	0.0016	0.00393	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP3A5—prostate cancer	0.00159	0.00391	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP3A5—prostate cancer	0.00157	0.00385	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—GSTA2—prostate cancer	0.00156	0.00383	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GSTA3—prostate cancer	0.00154	0.00377	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—GSTA3—prostate cancer	0.00152	0.00372	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—GSTA1—prostate cancer	0.00151	0.0037	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—HSP90AB1—prostate cancer	0.00146	0.00358	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GSTA4—prostate cancer	0.00141	0.00345	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—TBXAS1—prostate cancer	0.00141	0.00345	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—GSTA4—prostate cancer	0.00139	0.0034	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GSTA2—prostate cancer	0.00137	0.00336	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—SULT1A1—prostate cancer	0.00135	0.00332	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GGT1—prostate cancer	0.00134	0.00328	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—SULT1A1—prostate cancer	0.00134	0.00328	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—NFE2L2—prostate cancer	0.00133	0.00326	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GSTA1—prostate cancer	0.00132	0.00324	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—NAT2—prostate cancer	0.00131	0.00321	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GSTO1—prostate cancer	0.00131	0.00321	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—GSTO1—prostate cancer	0.00129	0.00316	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—NAT2—prostate cancer	0.00129	0.00316	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—TGFA—prostate cancer	0.00127	0.00311	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—GPX3—prostate cancer	0.00127	0.00311	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP2C18—prostate cancer	0.00125	0.00308	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP2C18—prostate cancer	0.00124	0.00303	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—COMT—prostate cancer	0.00121	0.00296	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GSTP1—prostate cancer	0.0012	0.00295	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—SULT2A1—prostate cancer	0.00117	0.00286	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—SULT2A1—prostate cancer	0.00115	0.00282	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—CYP2A6—prostate cancer	0.00114	0.0028	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GSTM1—prostate cancer	0.0011	0.00271	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—GPX3—prostate cancer	0.0011	0.00269	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—HPGDS—prostate cancer	0.00105	0.00256	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP2C19—prostate cancer	0.00104	0.00255	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP2C19—prostate cancer	0.00103	0.00251	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GSTT1—prostate cancer	0.00101	0.00249	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP2A6—prostate cancer	0.001	0.00246	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—SLC5A5—prostate cancer	0.000995	0.00244	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—CDKN1B—prostate cancer	0.000991	0.00243	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—IL2—prostate cancer	0.00097	0.00238	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—AKR1C3—prostate cancer	0.000962	0.00236	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—NQO1—prostate cancer	0.000961	0.00236	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP17A1—prostate cancer	0.00096	0.00235	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—HSPA1A—prostate cancer	0.000954	0.00234	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP17A1—prostate cancer	0.000947	0.00232	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—NCOA2—prostate cancer	0.000915	0.00224	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—EGR1—prostate cancer	0.000893	0.00219	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—GGT1—prostate cancer	0.000893	0.00219	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—EP300—prostate cancer	0.00087	0.00213	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP2E1—prostate cancer	0.000853	0.00209	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—SRC—prostate cancer	0.000846	0.00208	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP2E1—prostate cancer	0.000841	0.00206	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—RXRA—prostate cancer	0.000836	0.00205	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP3A4—prostate cancer	0.000822	0.00202	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP3A4—prostate cancer	0.000811	0.00199	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP1B1—prostate cancer	0.000808	0.00198	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—GSTP1—prostate cancer	0.000802	0.00197	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—TGFBR2—prostate cancer	0.000802	0.00197	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP1B1—prostate cancer	0.000797	0.00195	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GGT1—prostate cancer	0.000783	0.00192	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—NCOA1—prostate cancer	0.000771	0.00189	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP19A1—prostate cancer	0.00076	0.00186	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—TGFB1—prostate cancer	0.000757	0.00185	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP19A1—prostate cancer	0.00075	0.00184	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—EGFR—prostate cancer	0.000742	0.00182	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—GSTM1—prostate cancer	0.000737	0.00181	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—RXRA—prostate cancer	0.000734	0.0018	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—COMT—prostate cancer	0.000707	0.00173	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GSTP1—prostate cancer	0.000703	0.00172	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—COMT—prostate cancer	0.000697	0.00171	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—GSTP1—prostate cancer	0.000694	0.0017	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GSTM1—prostate cancer	0.000646	0.00158	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—GSTM1—prostate cancer	0.000637	0.00156	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP1A1—prostate cancer	0.000613	0.0015	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—HAO1—prostate cancer	0.000605	0.00148	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP1A1—prostate cancer	0.000604	0.00148	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ADI1—prostate cancer	0.000493	0.00121	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CBR1—prostate cancer	0.000493	0.00121	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—TST—prostate cancer	0.000493	0.00121	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CSAD—prostate cancer	0.000493	0.00121	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PSAT1—prostate cancer	0.000493	0.00121	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GRHL1—prostate cancer	0.000493	0.00121	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CKMT2—prostate cancer	0.000458	0.00112	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—UGT2B15—prostate cancer	0.000458	0.00112	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—UGT2B17—prostate cancer	0.000458	0.00112	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GRHPR—prostate cancer	0.000458	0.00112	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PGAM2—prostate cancer	0.000431	0.00106	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—SULT2B1—prostate cancer	0.000431	0.00106	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—NAGLU—prostate cancer	0.000431	0.00106	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—MBTPS1—prostate cancer	0.000431	0.00106	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GSTM3—prostate cancer	0.000431	0.00106	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—AOX1—prostate cancer	0.000431	0.00106	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—RFK—prostate cancer	0.000431	0.00106	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CYP3A43—prostate cancer	0.000408	0.001	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—SRD5A2—prostate cancer	0.000408	0.001	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—DEGS1—prostate cancer	0.000408	0.001	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—NAT1—prostate cancer	0.000408	0.001	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—AMACR—prostate cancer	0.000408	0.001	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—HSD17B1—prostate cancer	0.00039	0.000955	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—B4GALT4—prostate cancer	0.000347	0.000851	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—HPGD—prostate cancer	0.000347	0.000851	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—TNFRSF21—prostate cancer	0.000326	0.000801	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CYP7B1—prostate cancer	0.000318	0.000779	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—MTAP—prostate cancer	0.000318	0.000779	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—SULT1E1—prostate cancer	0.00031	0.000759	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—SRD5A1—prostate cancer	0.00031	0.000759	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—TGFB1—prostate cancer	0.0003	0.000736	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ACSL4—prostate cancer	0.000295	0.000724	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—HSD17B3—prostate cancer	0.000295	0.000724	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ARG2—prostate cancer	0.000283	0.000694	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PHGDH—prostate cancer	0.000283	0.000694	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—UMPS—prostate cancer	0.000283	0.000694	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—LDHB—prostate cancer	0.000278	0.000681	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CYP3A5—prostate cancer	0.000272	0.000668	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—UCP3—prostate cancer	0.000263	0.000645	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—TCN2—prostate cancer	0.000263	0.000645	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GSTA3—prostate cancer	0.000263	0.000645	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PDHA1—prostate cancer	0.000263	0.000645	CbGpPWpGaD
Deferiprone—Skin disorder—Etoposide—prostate cancer	0.000262	0.000469	CcSEcCtD
Deferiprone—Nausea—Goserelin—prostate cancer	0.000261	0.000467	CcSEcCtD
Deferiprone—Hyperhidrosis—Etoposide—prostate cancer	0.000261	0.000467	CcSEcCtD
Deferiprone—Pancreatitis—Epirubicin—prostate cancer	0.000261	0.000467	CcSEcCtD
Deferiprone—Nausea—Conjugated Estrogens—prostate cancer	0.000259	0.000463	CcSEcCtD
Deferiprone—Urticaria—Mitoxantrone—prostate cancer	0.000258	0.000462	CcSEcCtD
Deferiprone—Back pain—Capecitabine—prostate cancer	0.000257	0.000461	CcSEcCtD
Deferiprone—Hypersensitivity—Estradiol—prostate cancer	0.000257	0.000459	CcSEcCtD
Deferiprone—Abdominal pain—Mitoxantrone—prostate cancer	0.000257	0.000459	CcSEcCtD
Deferiprone—Body temperature increased—Mitoxantrone—prostate cancer	0.000257	0.000459	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Doxorubicin—prostate cancer	0.000257	0.000459	CcSEcCtD
Deferiprone—Eye disorder—Prednisone—prostate cancer	0.000255	0.000456	CcSEcCtD
Deferiprone—Pancytopenia—Epirubicin—prostate cancer	0.000253	0.000452	CcSEcCtD
Deferiprone—Hypotension—Etoposide—prostate cancer	0.000252	0.000452	CcSEcCtD
Deferiprone—Alanine aminotransferase increased—Doxorubicin—prostate cancer	0.000251	0.00045	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—SLC22A3—prostate cancer	0.000251	0.000616	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—HSD3B1—prostate cancer	0.000251	0.000616	CbGpPWpGaD
Deferiprone—Asthenia—Estradiol—prostate cancer	0.00025	0.000447	CcSEcCtD
Deferiprone—Neutropenia—Epirubicin—prostate cancer	0.000249	0.000445	CcSEcCtD
Deferiprone—Angiopathy—Prednisone—prostate cancer	0.000247	0.000442	CcSEcCtD
Deferiprone—Pruritus—Estradiol—prostate cancer	0.000246	0.000441	CcSEcCtD
Deferiprone—Immune system disorder—Prednisone—prostate cancer	0.000246	0.00044	CcSEcCtD
Deferiprone—Photosensitivity reaction—Epirubicin—prostate cancer	0.000243	0.000435	CcSEcCtD
Deferiprone—Weight increased—Epirubicin—prostate cancer	0.000242	0.000434	CcSEcCtD
Deferiprone—Pancreatitis—Doxorubicin—prostate cancer	0.000241	0.000432	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—GSTA4—prostate cancer	0.000241	0.00059	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—TBXAS1—prostate cancer	0.000241	0.00059	CbGpPWpGaD
Deferiprone—Somnolence—Etoposide—prostate cancer	0.00024	0.00043	CcSEcCtD
Deferiprone—Hypersensitivity—Mitoxantrone—prostate cancer	0.000239	0.000428	CcSEcCtD
Deferiprone—Pneumonia—Epirubicin—prostate cancer	0.000239	0.000427	CcSEcCtD
Deferiprone—Mental disorder—Prednisone—prostate cancer	0.000239	0.000427	CcSEcCtD
Deferiprone—Diarrhoea—Estradiol—prostate cancer	0.000238	0.000427	CcSEcCtD
Deferiprone—Convulsion—Docetaxel—prostate cancer	0.000238	0.000426	CcSEcCtD
Deferiprone—Hypertension—Docetaxel—prostate cancer	0.000237	0.000425	CcSEcCtD
Deferiprone—Infestation NOS—Epirubicin—prostate cancer	0.000237	0.000425	CcSEcCtD
Deferiprone—Infestation—Epirubicin—prostate cancer	0.000237	0.000425	CcSEcCtD
Deferiprone—Malnutrition—Prednisone—prostate cancer	0.000237	0.000424	CcSEcCtD
Deferiprone—Decreased appetite—Etoposide—prostate cancer	0.000235	0.00042	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—GSTA2—prostate cancer	0.000235	0.000575	CbGpPWpGaD
Deferiprone—Arthralgia—Docetaxel—prostate cancer	0.000234	0.000419	CcSEcCtD
Deferiprone—Pancytopenia—Doxorubicin—prostate cancer	0.000234	0.000419	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Etoposide—prostate cancer	0.000233	0.000417	CcSEcCtD
Deferiprone—Asthenia—Mitoxantrone—prostate cancer	0.000233	0.000417	CcSEcCtD
Deferiprone—Fatigue—Etoposide—prostate cancer	0.000233	0.000417	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000232	0.000416	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—SULT1A1—prostate cancer	0.000232	0.000568	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ABCG5—prostate cancer	0.000232	0.000568	CbGpPWpGaD
Deferiprone—Jaundice—Epirubicin—prostate cancer	0.000231	0.000414	CcSEcCtD
Deferiprone—Pain—Etoposide—prostate cancer	0.000231	0.000413	CcSEcCtD
Deferiprone—Neutropenia—Doxorubicin—prostate cancer	0.00023	0.000412	CcSEcCtD
Deferiprone—Hypertension—Capecitabine—prostate cancer	0.00023	0.000411	CcSEcCtD
Deferiprone—Arthralgia—Capecitabine—prostate cancer	0.000227	0.000406	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—GSTA1—prostate cancer	0.000226	0.000555	CbGpPWpGaD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000225	0.000403	CcSEcCtD
Deferiprone—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000225	0.000402	CcSEcCtD
Deferiprone—Hepatobiliary disease—Epirubicin—prostate cancer	0.000224	0.000402	CcSEcCtD
Deferiprone—Anaphylactic shock—Docetaxel—prostate cancer	0.000224	0.000402	CcSEcCtD
Deferiprone—Weight increased—Doxorubicin—prostate cancer	0.000224	0.000401	CcSEcCtD
Deferiprone—Discomfort—Capecitabine—prostate cancer	0.000224	0.000401	CcSEcCtD
Deferiprone—Epistaxis—Epirubicin—prostate cancer	0.000224	0.000401	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—NAT2—prostate cancer	0.000224	0.000549	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GSTO1—prostate cancer	0.000224	0.000549	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—HSD3B2—prostate cancer	0.000224	0.000549	CbGpPWpGaD
Deferiprone—Infection—Docetaxel—prostate cancer	0.000223	0.000399	CcSEcCtD
Deferiprone—Diarrhoea—Mitoxantrone—prostate cancer	0.000222	0.000398	CcSEcCtD
Deferiprone—Vomiting—Estradiol—prostate cancer	0.000221	0.000396	CcSEcCtD
Deferiprone—Agranulocytosis—Epirubicin—prostate cancer	0.000221	0.000396	CcSEcCtD
Deferiprone—Pneumonia—Doxorubicin—prostate cancer	0.000221	0.000395	CcSEcCtD
Deferiprone—Gastrointestinal pain—Etoposide—prostate cancer	0.000221	0.000395	CcSEcCtD
Deferiprone—Nervous system disorder—Docetaxel—prostate cancer	0.00022	0.000394	CcSEcCtD
Deferiprone—Rash—Estradiol—prostate cancer	0.00022	0.000393	CcSEcCtD
Deferiprone—Infestation NOS—Doxorubicin—prostate cancer	0.00022	0.000393	CcSEcCtD
Deferiprone—Infestation—Doxorubicin—prostate cancer	0.00022	0.000393	CcSEcCtD
Deferiprone—Dermatitis—Estradiol—prostate cancer	0.000219	0.000393	CcSEcCtD
Deferiprone—Headache—Estradiol—prostate cancer	0.000218	0.000391	CcSEcCtD
Deferiprone—Skin disorder—Docetaxel—prostate cancer	0.000218	0.00039	CcSEcCtD
Deferiprone—Infection—Capecitabine—prostate cancer	0.000216	0.000386	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—PLCB2—prostate cancer	0.000215	0.000526	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—LRP2—prostate cancer	0.000215	0.000526	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CYP2C18—prostate cancer	0.000215	0.000526	CbGpPWpGaD
Deferiprone—Urticaria—Etoposide—prostate cancer	0.000214	0.000384	CcSEcCtD
Deferiprone—Jaundice—Doxorubicin—prostate cancer	0.000214	0.000383	CcSEcCtD
Deferiprone—Abdominal pain—Etoposide—prostate cancer	0.000213	0.000382	CcSEcCtD
Deferiprone—Body temperature increased—Etoposide—prostate cancer	0.000213	0.000382	CcSEcCtD
Deferiprone—Nervous system disorder—Capecitabine—prostate cancer	0.000213	0.000381	CcSEcCtD
Deferiprone—Hepatitis—Epirubicin—prostate cancer	0.000213	0.000381	CcSEcCtD
Deferiprone—Pharyngitis—Epirubicin—prostate cancer	0.000211	0.000378	CcSEcCtD
Deferiprone—Skin disorder—Capecitabine—prostate cancer	0.000211	0.000378	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—P4HB—prostate cancer	0.00021	0.000516	CbGpPWpGaD
Deferiprone—Urinary tract disorder—Epirubicin—prostate cancer	0.00021	0.000377	CcSEcCtD
Deferiprone—Hyperhidrosis—Capecitabine—prostate cancer	0.00021	0.000376	CcSEcCtD
Deferiprone—Oedema peripheral—Epirubicin—prostate cancer	0.00021	0.000376	CcSEcCtD
Deferiprone—Hypotension—Docetaxel—prostate cancer	0.00021	0.000375	CcSEcCtD
Deferiprone—Connective tissue disorder—Epirubicin—prostate cancer	0.000209	0.000375	CcSEcCtD
Deferiprone—Urethral disorder—Epirubicin—prostate cancer	0.000209	0.000374	CcSEcCtD
Deferiprone—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000208	0.000372	CcSEcCtD
Deferiprone—Epistaxis—Doxorubicin—prostate cancer	0.000207	0.000371	CcSEcCtD
Deferiprone—Nausea—Estradiol—prostate cancer	0.000207	0.00037	CcSEcCtD
Deferiprone—Vomiting—Mitoxantrone—prostate cancer	0.000206	0.000369	CcSEcCtD
Deferiprone—Convulsion—Prednisone—prostate cancer	0.000205	0.000368	CcSEcCtD
Deferiprone—Agranulocytosis—Doxorubicin—prostate cancer	0.000205	0.000367	CcSEcCtD
Deferiprone—Hypertension—Prednisone—prostate cancer	0.000205	0.000366	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—SLC22A1—prostate cancer	0.000205	0.000502	CbGpPWpGaD
Deferiprone—Rash—Mitoxantrone—prostate cancer	0.000205	0.000366	CcSEcCtD
Deferiprone—Dermatitis—Mitoxantrone—prostate cancer	0.000204	0.000366	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000204	0.000366	CcSEcCtD
Deferiprone—Headache—Mitoxantrone—prostate cancer	0.000203	0.000364	CcSEcCtD
Deferiprone—Hypotension—Capecitabine—prostate cancer	0.000203	0.000363	CcSEcCtD
Deferiprone—Arthralgia—Prednisone—prostate cancer	0.000202	0.000361	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.0002	0.000359	CcSEcCtD
Deferiprone—Somnolence—Docetaxel—prostate cancer	0.000199	0.000357	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—SULT2A1—prostate cancer	0.000199	0.000489	CbGpPWpGaD
Deferiprone—Discomfort—Prednisone—prostate cancer	0.000199	0.000357	CcSEcCtD
Deferiprone—Eye disorder—Epirubicin—prostate cancer	0.000199	0.000356	CcSEcCtD
Deferiprone—Hypersensitivity—Etoposide—prostate cancer	0.000199	0.000356	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000198	0.000354	CcSEcCtD
Deferiprone—Cardiac disorder—Epirubicin—prostate cancer	0.000198	0.000354	CcSEcCtD
Deferiprone—Dyspepsia—Docetaxel—prostate cancer	0.000197	0.000354	CcSEcCtD
Deferiprone—Hepatitis—Doxorubicin—prostate cancer	0.000197	0.000353	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—MED12—prostate cancer	0.000196	0.000481	CbGpPWpGaD
Deferiprone—Pharyngitis—Doxorubicin—prostate cancer	0.000196	0.00035	CcSEcCtD
Deferiprone—Decreased appetite—Docetaxel—prostate cancer	0.000195	0.000349	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—GNG5—prostate cancer	0.000195	0.000477	CbGpPWpGaD
Deferiprone—Urinary tract disorder—Doxorubicin—prostate cancer	0.000195	0.000348	CcSEcCtD
Deferiprone—Oedema peripheral—Doxorubicin—prostate cancer	0.000194	0.000348	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000194	0.000347	CcSEcCtD
Deferiprone—Asthenia—Etoposide—prostate cancer	0.000194	0.000347	CcSEcCtD
Deferiprone—Connective tissue disorder—Doxorubicin—prostate cancer	0.000194	0.000347	CcSEcCtD
Deferiprone—Anaphylactic shock—Prednisone—prostate cancer	0.000193	0.000346	CcSEcCtD
Deferiprone—Fatigue—Docetaxel—prostate cancer	0.000193	0.000346	CcSEcCtD
Deferiprone—Angiopathy—Epirubicin—prostate cancer	0.000193	0.000346	CcSEcCtD
Deferiprone—Urethral disorder—Doxorubicin—prostate cancer	0.000193	0.000346	CcSEcCtD
Deferiprone—Nausea—Mitoxantrone—prostate cancer	0.000193	0.000345	CcSEcCtD
Deferiprone—Immune system disorder—Epirubicin—prostate cancer	0.000192	0.000344	CcSEcCtD
Deferiprone—Infection—Prednisone—prostate cancer	0.000192	0.000344	CcSEcCtD
Deferiprone—Mediastinal disorder—Epirubicin—prostate cancer	0.000192	0.000344	CcSEcCtD
Deferiprone—Pain—Docetaxel—prostate cancer	0.000192	0.000343	CcSEcCtD
Deferiprone—Dyspepsia—Capecitabine—prostate cancer	0.000191	0.000342	CcSEcCtD
Deferiprone—Chills—Epirubicin—prostate cancer	0.000191	0.000342	CcSEcCtD
Deferiprone—Pruritus—Etoposide—prostate cancer	0.000191	0.000342	CcSEcCtD
Deferiprone—Nervous system disorder—Prednisone—prostate cancer	0.00019	0.00034	CcSEcCtD
Deferiprone—Decreased appetite—Capecitabine—prostate cancer	0.000189	0.000338	CcSEcCtD
Deferiprone—Skin disorder—Prednisone—prostate cancer	0.000188	0.000336	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000188	0.000336	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—NCOA3—prostate cancer	0.000188	0.00046	CbGpPWpGaD
Deferiprone—Fatigue—Capecitabine—prostate cancer	0.000187	0.000335	CcSEcCtD
Deferiprone—Hyperhidrosis—Prednisone—prostate cancer	0.000187	0.000335	CcSEcCtD
Deferiprone—Mental disorder—Epirubicin—prostate cancer	0.000187	0.000334	CcSEcCtD
Deferiprone—Pain—Capecitabine—prostate cancer	0.000186	0.000333	CcSEcCtD
Deferiprone—Malnutrition—Epirubicin—prostate cancer	0.000185	0.000332	CcSEcCtD
Deferiprone—Diarrhoea—Etoposide—prostate cancer	0.000185	0.000331	CcSEcCtD
Deferiprone—Eye disorder—Doxorubicin—prostate cancer	0.000184	0.00033	CcSEcCtD
Deferiprone—Gastrointestinal pain—Docetaxel—prostate cancer	0.000183	0.000328	CcSEcCtD
Deferiprone—Cardiac disorder—Doxorubicin—prostate cancer	0.000183	0.000327	CcSEcCtD
Deferiprone—Back pain—Epirubicin—prostate cancer	0.000179	0.000321	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—HPGDS—prostate cancer	0.000179	0.000439	CbGpPWpGaD
Deferiprone—Angiopathy—Doxorubicin—prostate cancer	0.000179	0.00032	CcSEcCtD
Deferiprone—Immune system disorder—Doxorubicin—prostate cancer	0.000178	0.000319	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—CYP2C19—prostate cancer	0.000178	0.000436	CbGpPWpGaD
Deferiprone—Gastrointestinal pain—Capecitabine—prostate cancer	0.000178	0.000318	CcSEcCtD
Deferiprone—Mediastinal disorder—Doxorubicin—prostate cancer	0.000178	0.000318	CcSEcCtD
Deferiprone—Body temperature increased—Docetaxel—prostate cancer	0.000177	0.000318	CcSEcCtD
Deferiprone—Abdominal pain—Docetaxel—prostate cancer	0.000177	0.000318	CcSEcCtD
Deferiprone—Chills—Doxorubicin—prostate cancer	0.000177	0.000317	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000176	0.000316	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—GSTT1—prostate cancer	0.000174	0.000425	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ACHE—prostate cancer	0.000174	0.000425	CbGpPWpGaD
Deferiprone—Mental disorder—Doxorubicin—prostate cancer	0.000173	0.000309	CcSEcCtD
Deferiprone—Urticaria—Capecitabine—prostate cancer	0.000173	0.000309	CcSEcCtD
Deferiprone—Abdominal pain—Capecitabine—prostate cancer	0.000172	0.000307	CcSEcCtD
Deferiprone—Body temperature increased—Capecitabine—prostate cancer	0.000172	0.000307	CcSEcCtD
Deferiprone—Vomiting—Etoposide—prostate cancer	0.000172	0.000307	CcSEcCtD
Deferiprone—Malnutrition—Doxorubicin—prostate cancer	0.000172	0.000307	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—CYP2A6—prostate cancer	0.000172	0.000421	CbGpPWpGaD
Deferiprone—Dyspepsia—Prednisone—prostate cancer	0.00017	0.000305	CcSEcCtD
Deferiprone—Rash—Etoposide—prostate cancer	0.00017	0.000305	CcSEcCtD
Deferiprone—Dermatitis—Etoposide—prostate cancer	0.00017	0.000304	CcSEcCtD
Deferiprone—Headache—Etoposide—prostate cancer	0.000169	0.000303	CcSEcCtD
Deferiprone—Decreased appetite—Prednisone—prostate cancer	0.000168	0.000301	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—AKR1C3—prostate cancer	0.000167	0.000409	CbGpPWpGaD
Deferiprone—Fatigue—Prednisone—prostate cancer	0.000167	0.000299	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—PRKACB—prostate cancer	0.000166	0.000407	CbGpPWpGaD
Deferiprone—Back pain—Doxorubicin—prostate cancer	0.000166	0.000297	CcSEcCtD
Deferiprone—Hypersensitivity—Docetaxel—prostate cancer	0.000165	0.000296	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—CYP17A1—prostate cancer	0.000164	0.000403	CbGpPWpGaD
Deferiprone—Asthenia—Docetaxel—prostate cancer	0.000161	0.000288	CcSEcCtD
Deferiprone—Convulsion—Epirubicin—prostate cancer	0.000161	0.000288	CcSEcCtD
Deferiprone—Nausea—Etoposide—prostate cancer	0.00016	0.000287	CcSEcCtD
Deferiprone—Hypertension—Epirubicin—prostate cancer	0.00016	0.000287	CcSEcCtD
Deferiprone—Hypersensitivity—Capecitabine—prostate cancer	0.00016	0.000287	CcSEcCtD
Deferiprone—Pruritus—Docetaxel—prostate cancer	0.000159	0.000284	CcSEcCtD
Deferiprone—Gastrointestinal pain—Prednisone—prostate cancer	0.000158	0.000283	CcSEcCtD
Deferiprone—Arthralgia—Epirubicin—prostate cancer	0.000158	0.000283	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000157	0.000281	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—NCOA2—prostate cancer	0.000157	0.000384	CbGpPWpGaD
Deferiprone—Discomfort—Epirubicin—prostate cancer	0.000156	0.000279	CcSEcCtD
Deferiprone—Asthenia—Capecitabine—prostate cancer	0.000156	0.000279	CcSEcCtD
Deferiprone—Urticaria—Prednisone—prostate cancer	0.000154	0.000275	CcSEcCtD
Deferiprone—Pruritus—Capecitabine—prostate cancer	0.000154	0.000275	CcSEcCtD
Deferiprone—Diarrhoea—Docetaxel—prostate cancer	0.000154	0.000275	CcSEcCtD
Deferiprone—Body temperature increased—Prednisone—prostate cancer	0.000153	0.000274	CcSEcCtD
Deferiprone—Abdominal pain—Prednisone—prostate cancer	0.000153	0.000274	CcSEcCtD
Deferiprone—Anaphylactic shock—Epirubicin—prostate cancer	0.000151	0.000271	CcSEcCtD
Deferiprone—Infection—Epirubicin—prostate cancer	0.00015	0.000269	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—SLC5A5—prostate cancer	0.000149	0.000366	CbGpPWpGaD
Deferiprone—Convulsion—Doxorubicin—prostate cancer	0.000149	0.000266	CcSEcCtD
Deferiprone—Diarrhoea—Capecitabine—prostate cancer	0.000149	0.000266	CcSEcCtD
Deferiprone—Nervous system disorder—Epirubicin—prostate cancer	0.000148	0.000266	CcSEcCtD
Deferiprone—Hypertension—Doxorubicin—prostate cancer	0.000148	0.000265	CcSEcCtD
Deferiprone—Skin disorder—Epirubicin—prostate cancer	0.000147	0.000263	CcSEcCtD
Deferiprone—Hyperhidrosis—Epirubicin—prostate cancer	0.000146	0.000262	CcSEcCtD
Deferiprone—Arthralgia—Doxorubicin—prostate cancer	0.000146	0.000261	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—CYP2E1—prostate cancer	0.000146	0.000358	CbGpPWpGaD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000145	0.00026	CcSEcCtD
Deferiprone—Discomfort—Doxorubicin—prostate cancer	0.000144	0.000258	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—NQO1—prostate cancer	0.000144	0.000354	CbGpPWpGaD
Deferiprone—Vomiting—Docetaxel—prostate cancer	0.000143	0.000255	CcSEcCtD
Deferiprone—Hypersensitivity—Prednisone—prostate cancer	0.000143	0.000255	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—TH—prostate cancer	0.000142	0.000348	CbGpPWpGaD
Deferiprone—Rash—Docetaxel—prostate cancer	0.000141	0.000253	CcSEcCtD
Deferiprone—Hypotension—Epirubicin—prostate cancer	0.000141	0.000253	CcSEcCtD
Deferiprone—Dermatitis—Docetaxel—prostate cancer	0.000141	0.000253	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—CYP3A4—prostate cancer	0.000141	0.000345	CbGpPWpGaD
Deferiprone—Headache—Docetaxel—prostate cancer	0.000141	0.000252	CcSEcCtD
Deferiprone—Anaphylactic shock—Doxorubicin—prostate cancer	0.00014	0.000251	CcSEcCtD
Deferiprone—Infection—Doxorubicin—prostate cancer	0.000139	0.000249	CcSEcCtD
Deferiprone—Asthenia—Prednisone—prostate cancer	0.000139	0.000249	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—CYP1B1—prostate cancer	0.000138	0.000339	CbGpPWpGaD
Deferiprone—Vomiting—Capecitabine—prostate cancer	0.000138	0.000247	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000138	0.000247	CcSEcCtD
Deferiprone—Nervous system disorder—Doxorubicin—prostate cancer	0.000137	0.000246	CcSEcCtD
Deferiprone—Rash—Capecitabine—prostate cancer	0.000137	0.000245	CcSEcCtD
Deferiprone—Pruritus—Prednisone—prostate cancer	0.000137	0.000245	CcSEcCtD
Deferiprone—Dermatitis—Capecitabine—prostate cancer	0.000137	0.000245	CcSEcCtD
Deferiprone—Headache—Capecitabine—prostate cancer	0.000136	0.000244	CcSEcCtD
Deferiprone—Skin disorder—Doxorubicin—prostate cancer	0.000136	0.000243	CcSEcCtD
Deferiprone—Hyperhidrosis—Doxorubicin—prostate cancer	0.000135	0.000242	CcSEcCtD
Deferiprone—Somnolence—Epirubicin—prostate cancer	0.000135	0.000241	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—GGT1—prostate cancer	0.000134	0.000328	CbGpPWpGaD
Deferiprone—Nausea—Docetaxel—prostate cancer	0.000133	0.000239	CcSEcCtD
Deferiprone—Dyspepsia—Epirubicin—prostate cancer	0.000133	0.000238	CcSEcCtD
Deferiprone—Diarrhoea—Prednisone—prostate cancer	0.000132	0.000237	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—NCOA1—prostate cancer	0.000132	0.000323	CbGpPWpGaD
Deferiprone—Decreased appetite—Epirubicin—prostate cancer	0.000132	0.000236	CcSEcCtD
Deferiprone—Hypotension—Doxorubicin—prostate cancer	0.000131	0.000234	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000131	0.000234	CcSEcCtD
Deferiprone—Fatigue—Epirubicin—prostate cancer	0.00013	0.000234	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—CYP19A1—prostate cancer	0.00013	0.000319	CbGpPWpGaD
Deferiprone—Pain—Epirubicin—prostate cancer	0.000129	0.000232	CcSEcCtD
Deferiprone—Nausea—Capecitabine—prostate cancer	0.000129	0.000231	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000128	0.000228	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—RXRA—prostate cancer	0.000125	0.000308	CbGpPWpGaD
Deferiprone—Somnolence—Doxorubicin—prostate cancer	0.000124	0.000223	CcSEcCtD
Deferiprone—Gastrointestinal pain—Epirubicin—prostate cancer	0.000124	0.000222	CcSEcCtD
Deferiprone—Dyspepsia—Doxorubicin—prostate cancer	0.000123	0.000221	CcSEcCtD
Deferiprone—Vomiting—Prednisone—prostate cancer	0.000123	0.00022	CcSEcCtD
Deferiprone—Rash—Prednisone—prostate cancer	0.000122	0.000218	CcSEcCtD
Deferiprone—Dermatitis—Prednisone—prostate cancer	0.000122	0.000218	CcSEcCtD
Deferiprone—Decreased appetite—Doxorubicin—prostate cancer	0.000122	0.000218	CcSEcCtD
Deferiprone—Headache—Prednisone—prostate cancer	0.000121	0.000217	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000121	0.000216	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—COMT—prostate cancer	0.000121	0.000296	CbGpPWpGaD
Deferiprone—Fatigue—Doxorubicin—prostate cancer	0.000121	0.000216	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—GSTP1—prostate cancer	0.00012	0.000295	CbGpPWpGaD
Deferiprone—Urticaria—Epirubicin—prostate cancer	0.00012	0.000215	CcSEcCtD
Deferiprone—Pain—Doxorubicin—prostate cancer	0.00012	0.000214	CcSEcCtD
Deferiprone—Body temperature increased—Epirubicin—prostate cancer	0.00012	0.000214	CcSEcCtD
Deferiprone—Abdominal pain—Epirubicin—prostate cancer	0.00012	0.000214	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—ITPR1—prostate cancer	0.000118	0.00029	CbGpPWpGaD
Deferiprone—Nausea—Prednisone—prostate cancer	0.000115	0.000206	CcSEcCtD
Deferiprone—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000114	0.000205	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—TYMS—prostate cancer	0.000112	0.000274	CbGpPWpGaD
Deferiprone—Hypersensitivity—Epirubicin—prostate cancer	0.000111	0.0002	CcSEcCtD
Deferiprone—Urticaria—Doxorubicin—prostate cancer	0.000111	0.000199	CcSEcCtD
Deferiprone—Body temperature increased—Doxorubicin—prostate cancer	0.000111	0.000198	CcSEcCtD
Deferiprone—Abdominal pain—Doxorubicin—prostate cancer	0.000111	0.000198	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—GSTM1—prostate cancer	0.000111	0.000271	CbGpPWpGaD
Deferiprone—Asthenia—Epirubicin—prostate cancer	0.000109	0.000194	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—LPL—prostate cancer	0.000108	0.000266	CbGpPWpGaD
Deferiprone—Pruritus—Epirubicin—prostate cancer	0.000107	0.000192	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—CYP1A1—prostate cancer	0.000105	0.000257	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ERCC2—prostate cancer	0.000104	0.000255	CbGpPWpGaD
Deferiprone—Diarrhoea—Epirubicin—prostate cancer	0.000104	0.000185	CcSEcCtD
Deferiprone—Hypersensitivity—Doxorubicin—prostate cancer	0.000103	0.000185	CcSEcCtD
Deferiprone—Asthenia—Doxorubicin—prostate cancer	0.0001	0.00018	CcSEcCtD
Deferiprone—Pruritus—Doxorubicin—prostate cancer	9.91e-05	0.000177	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—MTHFR—prostate cancer	9.77e-05	0.000239	CbGpPWpGaD
Deferiprone—Vomiting—Epirubicin—prostate cancer	9.62e-05	0.000172	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—PPARA—prostate cancer	9.58e-05	0.000235	CbGpPWpGaD
Deferiprone—Diarrhoea—Doxorubicin—prostate cancer	9.58e-05	0.000172	CcSEcCtD
Deferiprone—Rash—Epirubicin—prostate cancer	9.54e-05	0.000171	CcSEcCtD
Deferiprone—Dermatitis—Epirubicin—prostate cancer	9.53e-05	0.000171	CcSEcCtD
Deferiprone—Headache—Epirubicin—prostate cancer	9.48e-05	0.00017	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—CAV1—prostate cancer	9.01e-05	0.000221	CbGpPWpGaD
Deferiprone—Nausea—Epirubicin—prostate cancer	8.99e-05	0.000161	CcSEcCtD
Deferiprone—Vomiting—Doxorubicin—prostate cancer	8.9e-05	0.000159	CcSEcCtD
Deferiprone—Rash—Doxorubicin—prostate cancer	8.83e-05	0.000158	CcSEcCtD
Deferiprone—Dermatitis—Doxorubicin—prostate cancer	8.82e-05	0.000158	CcSEcCtD
Deferiprone—Headache—Doxorubicin—prostate cancer	8.77e-05	0.000157	CcSEcCtD
Deferiprone—Nausea—Doxorubicin—prostate cancer	8.32e-05	0.000149	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—PIK3CG—prostate cancer	8.21e-05	0.000201	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—INS—prostate cancer	7.77e-05	0.00019	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CREBBP—prostate cancer	7.61e-05	0.000187	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PIK3CD—prostate cancer	7.21e-05	0.000177	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—NOS3—prostate cancer	6.81e-05	0.000167	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PIK3CB—prostate cancer	6.29e-05	0.000154	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PTGS2—prostate cancer	6.23e-05	0.000153	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PTEN—prostate cancer	5.43e-05	0.000133	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—EP300—prostate cancer	5.18e-05	0.000127	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PIK3CA—prostate cancer	3.83e-05	9.4e-05	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—AKT1—prostate cancer	3.13e-05	7.68e-05	CbGpPWpGaD
